PACIRA BIOSCIENCES, INC. Current Liabilities
PACIRA BIOSCIENCES, INC. (PCRX) had Current Liabilities of $122.01 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Liabilities, Current $122.01M.
- 2026-03-31: Liabilities, Current $108.79M.
- 2025-12-31: Liabilities, Current $120.59M.
- 2025-09-30: Liabilities, Current $107.08M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $122.01M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $108.79M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $120.59M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $107.08M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $313.16M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $314.73M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $309.92M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $306.40M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $92.69M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $93.44M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $97.38M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $93.66M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $108.91M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $98.70M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $147.77M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $131.53M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $133.18M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $305.07M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $521.12M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $225.79M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $228.69M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $232.08M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $253.33M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $86.27M 10-Q · filed 2020-10-30 | |
| 2020-06-30 | $70.58M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $80.31M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $107.67M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $95.84M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $83.00M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $58.99M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $60.66M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $54.52M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $53.02M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $48.37M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $56.22M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $52.34M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $57.51M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $45.65M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $44.84M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $146.83M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $150.44M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $146.14M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $149.79M 10-K · filed 2017-03-01 | $151.68M 10-K · filed 2016-02-25 |
| 2015-09-30 | $145.41M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $145.47M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $136.45M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $140.01M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $135.22M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $129.51M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $121.59M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $121.94M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $116.97M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $15.84M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $12.70M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $14.16M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $19.83M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $15.24M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $19.16M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $31.91M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $17.83M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $17.48M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $16.32M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |